Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
TSXV: RLV ● FRA: 6BXMarch 2, 2018
DISCLAIMERTHIS DOCUMENT HAS BEEN PREPARED BY RELEVIUM TECHNOLOGIES INC. (THE “COMPANY”) SOLELY FOR INFORMATION PURPOSES. THISDOCUMENT DOES NOT CONSTITUTE AN OFFERING DOCUMENT. THIS DOCUMENT IS THE SOLE RESPONSIBILITY OF THE COMPANY. INFORMATIONCONTAINED HEREIN DOES NOT PURPORT TO BE COMPLETE AND IS SUBJECT TO CERTAIN QUALIFICATIONS AND ASSUMPTIONS AND SHOULD NOTBE RELIED UPON FOR THE PURPOSE OF MAKING AN INVESTMENT IN THE COMPANY’S SECURITIES OR ENTERING INTO ANY TRANSACTION INRELATION THEREWITH. THE INFORMATION AND OPINIONS CONTAINED IN THIS DOCUMENT ARE PROVIDED AS AT THE DATE HEREOF AND ARESUBJECT TO CHANGE WITHOUT NOTICE AND, IN FURNISHING THIS DOCUMENT, THE COMPANY DOES NOT UNDERTAKE OR AGREE TO ANYOBLIGATION TO PROVIDE RECIPIENTS WITH ACCESS TO ANY ADDITIONAL INFORMATION OR TO UPDATE OR CORRECT THE DOCUMENT. THISDOCUMENT, NOR HAS IT REVIEWED THIS DOCUMENT.
FORWARD LOOKING INFORMATIONCERTAIN OF THE INFORMATION CONTAINED IN THIS PRESENTATION MAY CONTAIN “FORWARD-LOOKING INFORMATION”. FORWARD-LOOKINGINFORMATION AND STATEMENTS MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE FUTURE PLANS, COSTS, OBJECTIVES ORPERFORMANCE OF THE COMPANY, OR THE ASSUMPTIONS UNDERLYING ANY OF THE FOREGOING. IN THIS PRESENTATION, WORDS SUCH AS“MAY”, “WOULD”, “COULD”, “WILL”, “LIKELY”, “BELIEVE”, “EXPECT”, “ANTICIPATE”, “INTEND”, “PLAN”, “ESTIMATE” AND SIMILAR WORDS AND THENEGATIVE FORM THEREOF ARE USED TO IDENTIFY FORWARD-LOOKING STATEMENTS. FORWARD-LOOKING STATEMENTS SHOULD NOT BE READAS GUARANTEES OF FUTURE PERFORMANCE OR RESULTS, AND WILL NOT NECESSARILY BE ACCURATE INDICATIONS OF WHETHER, OR THE TIMESAT OR BY WHICH, SUCH FUTURE PERFORMANCE WILL BE ACHIEVED. FORWARD-LOOKING STATEMENTS AND INFORMATION ARE BASED ONINFORMATION AVAILABLE AT THE TIME AND/OR MANAGEMENT’S GOOD-FAITH BELIEF WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TOKNOWN OR UNKNOWN RISKS, UNCERTAINTIES, ASSUMPTIONS AND OTHER UNPREDICTABLE FACTORS, MANY OF WHICH ARE BEYOND THECOMPANY’S CONTROL. THE COMPANY DOES NOT INTEND, NOR DOES THE COMPANY UNDERTAKE ANY OBLIGATION, TO UPDATE OR REVISE ANYFORWARD-LOOKING INFORMATION OR STATEMENTS CONTAINED IN THIS PRESENTATION TO REFLECT SUBSEQUENT INFORMATION, EVENTS ORCIRCUMSTANCES OR OTHERWISE, EXCEPT IF REQUIRED BY APPLICABLE LAWS.
TSXV:RLV ● FRA:6BX
WHO WE ARE
3
WE ARE a Brand Acquisition Company
WE FOCUS on Health & Wellness
WE PREFER E-Commerce Brands
TSXV:RLV ● FRA:6BX
HOW WE CREATE VALUE
4
WE Acquire E-Brands at 4X EBIT
WE Build Brand Equity (Marketing & New Products)
WE Leverage Great People and Technology
TSXV:RLV ● FRA:6BX 5
Andre Godin - Chairman• EVP & CFO, IntelGenx Corp• Biotech and Pharma• Strength: Finance & Strategy
Pierre Bertrand - Director• CEO, Essilor Canada• Biotech, Pharma and Consumer Products• Strength: Mergers & Acquisitions
Tina Sampalis, - Director• President, Vanguard
Strategic Consulting • Medicine, Biotech and Pharma• Strength: Product Development
Michel Timperio - Director• VP Strategic Development, Neptune
Technologies • Biotech and Pharma• Strength: Business Development
LEADERSHIP
Aurelio Useche – CEO • Green-tech, Technology and
Natural Resources and • Strength: Strategy and
Operations Management
TSXV:RLV ● FRA:6BX
SOLID MARKETPLACE
6
Source: http://www.businessinsider.com/e-commerce-disrupting-health-and-personal-care-market-2015-4
HEALTH AND WELLNESS MARKET
ü A Worldwide $3.7 Trillion Industry
ü Less than 10% of sales online vs. 20-30% in other segments
ü Online Business Estimated to grow 17% per year
TSXV:RLV ● FRA:6BX
RLV ACQUISITION STRATEGY
7
PROFILE AND RISK
ü Brands with revenues between $2M - $20M
ü Average 4X EBIT
ü Shared Transaction Risk
STRATEGIC OUTCOME
ü Accrete Talent
ü Build Brand Awareness across platforms & geographies
ü Drive efficiencies through economies of scale
TSXV:RLV ● FRA:6BX 8
HEALTH & WELLNESS
Supplements
Mind and Body
Nutrition
Natural Health
Skin Care
RLV BRAND STRATEGY
Active Life
TSXV:RLV ● FRA:6BX
RLV TODAY
9
OPERATING PLATFORMwww.bioganix.com
EXCLUSIVE PARTNERSHempco, Tersus, Phyto
MARKETING MACHINEAutomationArtificial IntelligenceNew Technology B/C
BUILD BRAND EQUITYRebrandRepositionExpand
FINANCIAL POSITION
1. TRIPLED MARKET CAP
2. STRONGER BALANCE SHEET
3. CASH POSITIVE ASSET
4. EXCELLENT LIQUIDITY
5. INNOVATION FINANCE
TSXV:RLV ● FRA:6BX 10
2017 Milestones
JULY AUGUST SEPTEMBER OCTOBER
MARKET GUIDANCEBGX SPORT
CONTROLOFBIOGANIX
PET BRANDAI BIG DATA
NOVEMBER DECEMBER
ABIS HEMPCO PROVINAL
TSXV:RLV ● FRA:6BX 11
2018 Plan Timeline
JAN FEB MAR APR
REBRAND GUIDANCESETTING
THE STAGE FOR JV
LAUNCH OF:HEMPOMEGA 7BGX GOLDCURALOE
MAY JUN
JV FINANCE STRATEGICPARTNERS
SECOND WAVE NEW PRODUCTS
EYE ON NEXT ACQUISITION
TSXV:RLV ● FRA:6BX
M&A PIPELINE
12
PIPELINE DETAILS
§ Supports Roll-Up Strategy
§ Average EBIT of 31%
§ Acquisition Multiple 4.4 (Avg)
TSXV:RLV ● FRA:6BX
MARKET COMPARABLES
13
TSXV:RLV ● FRA:6BX
CORPORATE PROFILE
14
GENERAL INFORMATIONSector: Consumer HealthcareTSX Venture: “RLV-V”OTCQB: “RLLVF” Frankfurt: “6BX”Headquarters: Montreal
TRADING INFORMATIONPrice: $0.19
Market Cap: $17MAVG Volume: 700K shares
52-week: $0.085-0.35
CAPITAL STRUCTUREShares O/S: 87MOptions (@0.168): 4.4MWarrants (@0.148): 31M Shares F/D: 122M
KEY HOLDINGSInsiders: 15% Escrowed: 5%
Free Trading: 80%
TSXV: RLV